Topoisomerases and Cardiotoxicity
TopoGEN products (Top2a) were used in the following study published in Nature. This is a very exciting and powerful result suggesting novel inroads to addressing the problem of cardiotoxicity. In this work, authors develop obex inhibitors that target a distinct binding pocket in the ATPase domain of Topoisomerase II. They demonstrate how Topobexin, a Topoisomerase […]